Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial von Moskowitz, Craig H, Dr Prof, Nademanee, Auayporn, Prof, Masszi, Tamas, Prof, Agura, Edward, Prof, Holowiecki, Jerzy, Prof, Abidi, Muneer H, Prof, Chen, Andy I, Prof, Stiff, Patrick, Prof, Gianni, Alessandro M, Prof, Carella, Angelo, Prof, Osmanov, Dzhelil, Prof, Bachanova, Veronika, Prof, Sweetenham, John, Prof, Sureda, Anna, Prof, Huebner, Dirk, MD, Sievers, Eric L, MD, Chi, Andy, PhD, Larsen, Emily K, MS, Hunder, Naomi N, MD, Walewski, Jan, Prof

Volltext

Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse von Moskowitz, Craig H., Walewski, Jan, Nademanee, Auayporn, Masszi, Tamas, Agura, Edward, Holowiecki, Jerzy, Abidi, Muneer H., Chen, Andy I., Stiff, Patrick, Viviani, Simonetta, Bachanova, Veronika, Sureda, Anna, McClendon, Teresa, Lee, Connie, Lisano, Julie, Sweetenham, John

Volltext

Did brentuximab vedotin's rise to the top ECHELON of Hodgkin therapeutics invalidate AETHERA results? von Hamadani, Mehdi

Volltext

Quality of life EQ-5D results from the AETHERA trial: A phase III study of brentuximab vedotin consolidation following autologous stem cell transplant for HL von Ramsey, Scott David, Nademanee, Auayporn, Masszi, Tamás, Holowiecki, Jerzy, Abidi, Muneer, Chen, Andy I., Stiff, Patrick J., Viviani, Simonetta, Zhu, Yanyan, Bonthapally, Vijayveer, Thomas, Elizabeth, Hunder, Naomi N. H., Walewski, Jan Andrzej

Volltext

Multivariate analysis of PFS from the AETHERA trial: A phase III study of brentuximab vedotin consolidation after autologous stem cell transplant for HL von Walewski, Jan Andrzej, Nademanee, Auayporn, Masszi, Tamás, Holowiecki, Jerzy, Abidi, Muneer, Chen, Andy I., Stiff, Patrick J., Viviani, Simonetta, Bachanova, Veronika, Sweetenham, John W., Lee, Shih-Yuan, Huebner, Dirk, Larsen, Emily K., Hunder, Naomi N. H., Moskowitz, Craig H.

Volltext

Updated Efficacy and Safety Data from the AETHERA Trial of Consolidation with Brentuximab Vedotin after Autologous Stem Cell Transplant (ASCT) in Hodgkin Lymphoma Patients at High Risk of Relapse von Sweetenham, John, Walewski, Jan, Nademanee, Auayporn P., Masszi, Tamas, Agura, Edward, Holowiecki, Jerzy, Abidi, Muneer H., Chen, Andy I, Stiff, Patrick, Viviani, Simonetta, Carella, Angelo Michele, Osmanov, Dzhelil, Bachanova, Veronika, Sureda, Anna, Huebner, Dirk, Larsen, Emily K, Hunder, Naomi N, Moskowitz, Craig H

Volltext

The Aethera Trial: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at Risk of Progression Following Autologous Stem Cell Transplant for Hodgkin Lymphoma von Moskowitz, Craig H., Nadamanee, Auayporn, Masszi, Tamas, Agura, Edward, Holowiecki, Jerzy, Abidi, Muneer H., Chen, Andy I, Stiff, Patrick J., Gianni, Alessandro M., Carella, Angelo M., Osmanov, Dzhelil, Bachanova, Veronika, Sweetenham, John, Sureda, Anna, Huebner, Dirk, Larsen, Emily K., Hunder, Naomi N.H., Walewski, Jan

Volltext

Safety Analysis of Brentuximab Vedotin from the Phase III AETHERA Trial in Hodgkin Lymphoma in the Post-Transplant Consolidation Setting von Nademanee, Auayporn, Sureda, Anna, Stiff, Patrick, Holowiecki, Jerzy, Abidi, Muneer, Hunder, Naomi, Pecsok, Michael, Uttarwar, Mayur, Purevjal, Indra, Sweetenham, John

Volltext

T031 (0110) FIVE‐YEAR PROGRESSION‐FREE SURVIVAL OUTCOMES FROM A PIVOTAL PHASE 3 STUDY OF CONSOLIDATIVE BRENTUXIMAB VEDOTIN AFTER AUTOLOGOUS STEM CELL TRANSPLANT IN PATIENTS WITH HODGKIN LYMPHOMA AT RISK OF RELAPSE OR PROGRESSION (AETHERA)

Volltext

Updated Efficacy and Safety Data From the AETHERA Trial of Consolidation With Brentuximab Vedotin After Autologous Stem Cell Transplant (ASCT) in Hodgkin Lymphoma Patients at High Risk of Relapse

Volltext

Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real‐life experience von Massaro, Fulvio, Pavone, Vincenzo, Stefani, Piero Maria, Botto, Barbara, Pulsoni, Alessandro, Patti, Caterina, Cantonetti, Maria, Visentin, Andrea, Scalzulli, Potito Rosario, Rossi, Andrea, Galimberti, Sara, Cimminiello, Michele, Gini, Guido, Musso, Maurizio, Sorio, Marco, Arcari, Annalisa, Zilioli, Vittorio Ruggero, Luppi, Mario, Mannina, Donato, Fabbri, Alberto, Pietrantuono, Giuseppe, Annibali, Ombretta, Tafuri, Agostino, Prete, Eleonora, Mulè, Antonino, Barbolini, Elisa, Marcheselli, Luigi, Luminari, Stefano, Merli, Francesco

Volltext

Outcomes in Hodgkin Lymphoma Patients Following Allogeneic Transplant after Post-Autologous Transplant Consolidation Therapy with Brentuximab Vedotin: Results of an Exploratory Analysis in the AETHERA Trial von Cashen, Amanda, Agura, Edward, Matous, Jeffrey, Arai, Sally, Chen, Andy I, Nadamanee, Auayporn, García-Sanz, Ramón, Carella, Angelo, Huebner, Dirk, Larsen, Emily K, Pinelli, Juan, Bachanova, Veronika

Volltext

23 - Outcomes in Hodgkin Lymphoma Patients Following Allogeneic Transplant after Post-Autologous Transplant Consolidation Therapy with Brentuximab Vedotin: Results of an Exploratory Analysis in the AETHERA Trial von Cashen, Amanda, Agura, Edward, Matous, Jeffrey, Arai, Sally, Chen, Andy I., Nadamanee, Auayporn, García-Sanz, Ramón, Carella, Angelo, Huebner, Dirk, Larsen, Emily K., Pinelli, Juan, Bachanova, Veronika

Volltext

Updated Efficacy and Safety Data from the AETHERA Trial of Consolidation with Brentuximab Vedotin after Autologous Stem Cell Transplant (ASCT) in Hodgkin Lymphoma Patients at High Risk of Relapse von Sweetenham, John W., MD, FRCP, Walewski, Jan, MD, Nadamanee, Auayporn, MD, Masszi, Tamas, MD, PhD, Agura, Edward, MD, Holowiecki, Jerzy, MD, PhD, Abidi, Muneer H., MD, Chen, Andy I., MD, PhD, Stiff, Pat, MD, Viviani, Simonetta, Carella, Angelo, MD, Osmanov, Dzhelil, MD, Bachanova, Veronika, MD, PhD, Sureda, Anna, MD, PhD, Huebner, Dirk, MD, Larsen, Emily K., MS, Hunder, Naomi N., MD, Moskowitz, Craig H., MD

Volltext

The AETHERA Trial: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at Risk of Progression Following Autologous Stem Cell Transplant for Hodgkin Lymphoma von Moskowitz, Craig H., MD, Nadamanee, Auayporn, MD, Masszi, Tamas, MD, PhD, Agura, Edward, MD, Holowiecki, Jerzy, MD, PhD, Abidi, Muneer H., MD, Chen, Andy, MD, PhD, Stiff, Patrick J., MD, Gianni, Alessandro M., MD, Carella, Angelo M., MD, Osmanov, Dzhelil, MD, Bachanova, Veronika, MD, Sweetenham, John, MD, Sureda, Anna, MD, Huebner, Dirk, MD, Larsen, Emily K., MS, Hunder, Naomi N.H., MD, Walewski, Jan, MD

Volltext

The Aethera Trial: An Ongoing Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at High Risk of Residual Hodgkin Lymphoma Following Autologous Stem Cell Transplant von Moskowitz, Craig, Nadamanee, Auayporn, Masszi, Tamas, Agura, Edward, Holowiecki, Jerzy, Abidi, Muneer, Chen, Andy, Stiff, Patrick, Gianni, Alessandro, Carella, Angelo, Osmanov, Dzhelil, Sweetenham, John, Sureda, Anna, Huebner, Dirk, Hunder, Naomi, Yang, Yin, Walewski, Jan

Volltext

Pandosion sphaericum in quo singula in elementaribus regionibus, atque aethera, mathematicè pertractantur (Reprod.) / Andrea Argoli von Argoli, Andrea (1570-1653). Auteur du texte

Volltext bestellen

"PER LIQUIDUM AETHERA VATES.": I. II. III. IV. V von WHITMORE

Volltext

Per Liquidum Aethera Vates

Volltext

Vir Fama super Aethera Notus Eginhartus von Weinckens, Johannes

Volltext bestellen